Hypovase 0.5 mg tablets – Deletion of all indications of paediatric use of prazosin
08/03/2024
Medicines for human use
Product information update (PIU)
This update is to inform healthcare professionals of a recent update to the product information for Hypovase 0.5 mg tablets, (prazosin hydrochloride). This update relates to the deletion all indications of paediatric use of prazosin in the Summary of Product Characteristics and Patient Information Leaflet.
Please see the document linked below for further information.
Product information
- Active substance
- Prazosin hydrochloride
- Authorisation holder
- Pfizer Healthcare Ireland
- Authorisation number
- PA0822/195/001
- Human or veterinary medicine
- Human Medicine